March 2020 – Clinical, regulatory and pharmacovigilance solution provider to the global life science industry, Biomapas, appointed leading pharmacovigilance professional Martijn van de Leur as Head of Global Pharmacovigilance.
With offices located in Lithuania, Switzerland, Sweden, Russia, Georgia, Ukraine and Poland, Biomapas provides services in 60+ countries across 4 continents. As a functional and full outsourcing solution provider, Biomapas continues to strengthen its international team and geographical coverage of its services globally.
Martijn brings over a decade of pharmacovigilance and drug safety experience, previously acting as Global Head of Drug Safety at Vifor Pharma, and further back in his career working as Pharmacovigilance Lead at Merck.
Proven leader with significant business growth experience, Martijn will play an important role in the provision of the pharmacovigilance department, ensuring the highest quality standards and maximizing the efficiency of pharmacovigilance activities globally. Martijn will be responsible for daily operations and will work on the implementation of Biomapas strategic goals.
“Martijn is the highest-level pharmacovigilance professional in the global market, with a proven track record of success in the management of global drug safety technologies and leadership of pharmacovigilance teams. Martijn brings us a wealth of experience in automation and new technologies and drug safety management. His expertise to lead teams and orientation towards customer satisfaction makes him a valuable addition to our global team, “ said Juozas Buitkus, Biomapas COO.
Martijn van de Leur graduated from RadBoud University with a specialization in Pathobiology and Oncology. Since 2005, he works in the life science industry concentrating in pharmacovigilance area. As a senior leader in pharmacovigilance and experienced (Deputy) EU QPPV, Martijn has a broad network within the industry and is a known industry speaker with excellent experience in drug safety.
About Biomapas
Biomapas is a functional and full outsourcing solution provider to the global life science industry, with key expertise in Clinical Trials, Regulatory Affairs and Pharmacovigilance. The company has a significant presence across the CEE, Nordic and CIS countries thereby offering fast and reliable patient recruitment for Phase I-IV and medical device clinical trials, while regulatory and pharmacovigilance services are provided across 4 continents. We are committed to customer service and satisfaction.
